Ultralife (ULBI) director buys 1,750 shares at $5.67 each
Ultralife Corp (ULBI) director share purchase reported.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Ultralife Corp (ULBI) director share purchase reported. A company director filed a Form 4 disclosing the open-market purchase of 1,750 shares of Ultralife Corp common stock on 11/24/2025 at a price of $5.67 per share. Following this transaction, the director now beneficially owns 71,000 shares held directly. The filing notes the transaction as a purchase of non-derivative common stock and indicates it was reported by a single reporting person.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock; $.10 par value | 1,750 | $5.67 | $10K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Ultralife Corp (ULBI) report on this Form 4?
What is the relationship of the reporting person to Ultralife Corp (ULBI)?
Does this Ultralife Corp (ULBI) Form 4 involve derivative securities?
Is the Ultralife Corp (ULBI) Form 4 filed by one or multiple insiders?
AI-generated analysis. How Rhea-AI works. Not financial advice.